SkinnyRx Review
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Reader-supported, we may earn a commission through links on this site. Rankings are editorially independent. Disclosure · Methodology
Quick Verdict
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Who it's for: SkinnyRx is the broadest GLP-1 catalog in this list. Best for readers who want optionality, different routes of administration (injection, oral, sublingual) and the ability to move between compounded and brand-name medications without changing clinics. The breadth of delivery formats — injectable, oral, sublingual — is the clearest differentiator. If you want maximum optionality across GLP-1 modalities rather than a single standardised protocol, SkinnyRx has the widest menu in the category.
Bottom line: Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.
- All major brand-name GLP-1s available
- Multiple administration routes per molecule
- Includes newer orforglipron (Foundayo)
- Higher entry price than entry-level competitors
- Single-category, no men's, women's, or longevity adjuncts
Pros & Cons In Detail
SkinnyRx Pricing
Telehealth ads often advertise a low headline price that's the clinic's program fee, not the medication. Here's how the two line items break down at SkinnyRx.
| Program / Membership Fee | Included in monthly plan |
| Medication Cost (From) | From $149 – $449/mo |
Bundled monthly pricing covers the compounded medication and provider oversight; brand-name GLP-1s are passed through at clinic-published rates plus a service fee.
Who SkinnyRx Is For
SkinnyRx is the broadest GLP-1 catalog in this list. Best for readers who want optionality, different routes of administration (injection, oral, sublingual) and the ability to move between compounded and brand-name medications without changing clinics. The breadth of delivery formats — injectable, oral, sublingual — is the clearest differentiator. If you want maximum optionality across GLP-1 modalities rather than a single standardised protocol, SkinnyRx has the widest menu in the category.
Adults who want clinician-guided access to every major GLP-1 modality: including newer orforglipron.
Signature Programs
- ›Injectable, oral, and sublingual compounded GLP-1
- ›All four major brand-name GLP-1s
- ›Orforglipron (Foundayo)
Medication Formulary
The Bottom Line
Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.
With an editor score of 4.3 / 5 across cost, experience, and trust, SkinnyRx is one of the strong mid-tier options in the glp-1 weight loss category we cover.
See how SkinnyRx compares in our full glp-1 weight loss rankings, or read the Best Telehealth GLP-1 Providers guide. Our methodology explains how we score each provider.
Frequently Asked Questions
- Wharton et al., NEJM 2025 (ATTAIN-1) · ATTAIN-1 trial: orforglipron 36 mg produced 7.9% placebo-adjusted weight loss at 36 weeks in adults with obesity.
- Wilding et al., NEJM 2021 (STEP 1) · Semaglutide 2.4 mg produced 14.9% mean weight loss vs 2.4% placebo at 68 weeks in the STEP 1 trial.
- Garvey et al., NEJM 2022 (STEP 5) · Two-year STEP 5 data confirmed sustained 15.2% weight loss with semaglutide 2.4 mg.
- Jastreboff et al., NEJM 2022 (SURMOUNT-1) · Tirzepatide 15 mg produced 20.9% mean weight loss vs 3.1% placebo at 72 weeks in SURMOUNT-1.
RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.